Justin L. Chen
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
TMEPAI/PMEPA1 Is a Positive Regulator of Skeletal Muscle Mass.
Journal: Frontiers in physiology
Published: May 08, 2020
Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 14, 2017
Induction of experimental autoimmune orchitis in mice: responses to elevated circulating levels of the activin-binding protein, follistatin.
Journal: Reproduction (Cambridge, England)
Published: January 05, 2017
The TGF-β Signalling Network in Muscle Development, Adaptation and Disease.
Journal: Advances in experimental medicine and biology
Published: March 23, 2016
Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia.
Journal: Cancer research
Published: November 17, 2015
Smad7 gene delivery prevents muscle wasting associated with cancer cachexia in mice.
Journal: Science translational medicine
Published: May 04, 2015
Development of novel activin-targeted therapeutics.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 05, 2014
The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass.
Journal: The Journal of cell biology
Published: October 23, 2013
Activin signaling regulates Sertoli cell differentiation and function.
Journal: Endocrinology
Published: November 03, 2012
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin.
Journal: The Journal of cell biology
Published: June 20, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026